 |
Calculating Risk and Return of Investments in a Portfolio (Part B)
Excel Supplement Available on Request for Faculty Member's only. Write to us at Case Help desk. casehelpdesk@ibsindia.org
INTRODUCTION
Dilip Shangvi (Shangvi), founder of Sun Pharmaceutical Industries (Sun Pharma) bought a 23 percent stake in Suzlon Energy Ltd. (Suzlon) for Rs 18000 million in February 2015. Earlier, in 2011, Shangvi had invested his personal wealth in Natco Pharma to buy a 3.5 percent stake for Rs 250 million and in an Israeli company, Bio-Light Sciences, to buy an 11 percent stake for Rs 140 million. Shangvi held a 60 percent stake in Sun Pharma and had received dividends worth more than Rs 12000 million between 2010 and 2015 and was looking for an avenue to invest the money, according to Sudhir Valia, Shangvi’s brother-in-law.. |
|
